Hot Topics In - Congress Reports
Use these Web pages for faster access to state-of the-art medical topics in various specialties to keep abreast of practical clinical information and research results.
Tuesday, 07 September 2010
You are here: Congress Reports
Latest news from...
European Association for the Study of the Liver Congress
Screening for HCV is still a major issue: even though 20 years have passed since the development of diagnostic assays for HCV, the diagnosis rate remains less than 25% across most of Europe. As reported by Ghany et al...
Bayer Schering Pharma’s 5th Pritor/Kinzal Standalone Symposium
Telmisartan - Setting a New Standard. Key opinion leaders presented and discussed the most important evidence that changed CVD treatment in recent years: specifically, data from the ONTARGET/TRANSCEND studies regarding telmisartan...
European Respiratory Society Congress
New perspectives in COPD treatment: indacaterol, roflumilast, tiotropium; focus on the UPLIFT trial, H1N1 influenza, smoking cessation, lung cancer and PMM, PAH diagnosis and treatment...
European Society of Cardiology Congress, Issue I
New perspectives from the ONTARGET/TRASCEND study, evidence on ARBs, BP lowering and the J-curve, possible benefits of low-dose aspirin in primary prevention of CV disease, interview to Professor H. Haller...
European Society of Cardiology Congress, Issue II
Evidence from the latest trials: RE-LY, MADIT-CRT, PLATO, PROTECT; perspectives about otamixaban, telmisartan, and clopidogrel, management of patients with ACS...
European Society of Hypertension Congress
Possible drug combinations, evidence on ARBs, prognosis of organ damage, BP control in children and adolescents, analysis of the ONTARGET/TRASCEND trial, ESH guidelines and further perspectives...
European Association for the Study of the Liver
Evidence and perspectives concerning HBsAg measurement, combination of direct antivirals againts HCV, boceprevir, telaprevir, albuferon, ribavirin...
